Quantcast
Last updated on April 25, 2014 at 1:22 EDT

Latest Metastasectomy Stories

2008-08-04 06:00:40

QUEBEC CITY, Aug. 4 /PRNewswire-FirstCall/ -- DiagnoCure Inc. (TSX: CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced today that four prominent colorectal cancer key opinion leaders have agreed to serve on the Strategic Advisory Board of its wholly owned subsidiary, DiagnoCure Oncology Laboratories. The Strategic Advisory Board is composed of Dr. Edith Mitchell, MD, FACP, Clinical Professor of Medicine &...

2008-05-29 09:01:17

CHICAGO, IL, May 29 /PRNewswire-FirstCall/ -- DiagnoCure Oncology Laboratories based in West Chester, PA, will exhibit at the American Society of Clinical Oncology Annual Meeting (ASCO) on May 30th-June 3rd in Chicago, Illinois. The Company's newly established sales force will be on hand to introduce Previstage(TM) GCC, the first molecular diagnostic test for the staging of colorectal cancer and educate clinicians on the science of guanylyl cyclase C (GCC). The histopathological status of...

2008-03-19 03:00:09

By Gazoni, Leo M Hedrick, Traci L; Smith, Philip W; Friel, Charles M; Swenson, Brian R; Adams, Joshua D; Lisle, Turner C; Foley, Eugene F; Ledesma, Elihu J Cutaneous metastases from rectal cancer are rare manifestations of disseminated disease and uniformly represent dismal survival. A retrospective review of six patients with rectal cancer metastatic to the dermis was performed. The diagnosis of rectal cancer was made concurrently with the diagnosis of the dermal metastases in all six...